Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Terapia Tecar en Pacientes con Radiculopatía Lumbar: Un Ensayo Controlado Aleatorizado

11 de noviembre de 2026 actualizado por: Izmir City Hospital

Eficacia de la Terapia Tecar frente a la Fisioterapia Convencional y el Tratamiento Simulado en Pacientes con Radiculopatía Lumbar: Un Ensayo Controlado Aleatorizado

Lumbar radiculopathy is a common cause of low back and leg pain, most frequently resulting from lumbar disc herniation and nerve root irritation. Conservative management, including physical therapy modalities and exercise therapy, is generally recommended as first-line treatment for patients without progressive neurological deficits. Tecar therapy (Transfer of Energy Capacitive and Resistive) is a non-invasive electrotherapeutic modality that delivers high-frequency electromagnetic energy to deep tissues and has been proposed to reduce pain, enhance microcirculation, and promote tissue recovery. However, evidence regarding its effectiveness in lumbar radiculopathy remains limited.

The aim of this randomized controlled trial is to evaluate the efficacy of Tecar therapy in patients with lumbar radiculopathy and to compare its clinical effects with conventional physical therapy and sham Tecar treatment.

A total of 90 participants with unilateral L5 and/or S1 radiculopathy will be randomized into three groups: (1) conventional physical therapy, (2) Tecar therapy combined with standard physical therapy, and (3) sham Tecar therapy combined with standard physical therapy. All participants will receive standardized postural education and a home exercise program.

The primary outcome will be radicular leg pain intensity measured by the Visual Analog Scale (VAS) at Week 2. Secondary outcomes will include low back pain intensity (VAS), functional disability (Oswestry Disability Index), neuropathic pain characteristics (PainDETECT questionnaire), lumbar mobility (Modified-Modified Schober Test), nerve root irritability (Straight Leg Raise test), rescue analgesic consumption, and exercise adherence. Outcomes will be assessed at baseline, post-treatment (week 2), and follow-up visits at weeks 6 and 12.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Descripción detallada

This assessor-blinded, randomized controlled trial will be conducted in the Department of Physical Medicine and Rehabilitation at İzmir City Hospital, a tertiary-level outpatient center. The study will be designed and reported according to CONSORT recommendations.

Participants aged 18-65 years with clinically diagnosed unilateral L5 and/or S1 radiculopathy and symptom duration between 6 weeks and 6 months will be eligible. Diagnosis will primarily be based on clinical findings consistent with radiculopathy, including dermatomal leg pain and supportive neurological examination findings, while lumbar MRI and/or EMG will be used as confirmatory evidence. After written informed consent is obtained, eligible participants will be randomly assigned in a 1:1:1 ratio to one of three groups using computer-generated randomization with concealed allocation.

Group 1 will receive conventional physical therapy consisting of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS). Group 2 will receive Tecar therapy in addition to standardized base therapy. Tecar treatment will include capacitive and resistive energy transfer applied to the lumbar paraspinal region and gluteal muscles. Group 3 will receive sham Tecar therapy using the same procedure as the active Tecar protocol but with zero energy output. All groups will additionally receive standardized postural education and a home exercise program.

Outcome assessments will be performed by an independent physiatrist blinded to group allocation at four time points: baseline, post-treatment (week 2), and follow-up visits at weeks 6 and 12. The primary outcome will be change in radicular leg pain intensity from baseline to Week 2, measured by the Visual Analog Scale (VAS). Secondary outcomes will include low back pain intensity (VAS), functional disability (Oswestry Disability Index), neuropathic pain features (PainDETECT questionnaire), lumbar mobility (Modified-Modified Schober Test), nerve root irritability assessed with the Straight Leg Raise test, rescue analgesic consumption, and exercise adherence.

The study aims to determine whether Tecar therapy provides additional clinical benefit over conventional physical therapy and to evaluate the effectiveness of Tecar therapy beyond placebo effects using a sham-controlled design.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

90

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Ertan Yilmaz, MD
  • Número de teléfono: +905318431901
  • Correo electrónico: ertnyilmzz@gmail.com

Ubicaciones de estudio

      • Izmir, Turquía (Türkiye), 35000
        • Reclutamiento
        • İzmir City Hospital
        • Contacto:
      • Izmir, Turquía (Türkiye)
        • Reclutamiento
        • İzmir Cİty Hospital
        • Contacto:
          • Ertan Yilmaz, Medical Doctor, Specialist
          • Número de teléfono: +905318431901
          • Correo electrónico: ertnyilmzz@gmail.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adults aged 18-65 years
  • Clinical diagnosis of unilateral L5 and/or S1 lumbar radiculopathy
  • Symptom duration between 6 weeks and 6 months
  • Average radicular pain intensity ≥3 on the Visual Analog Scale (VAS) during the previous month
  • Availability of lumbar MRI and/or EMG performed within the previous 6 months
  • Willingness to participate and ability to provide written informed consent

Exclusion Criteria:

  • Bilateral lumbar radiculopathy
  • Lumbar spinal canal stenosis confirmed by imaging or suspected clinically (e.g., neurogenic claudication)
  • Lower limb muscle strength <4/5 according to the Medical Research Council (MRC) scale
  • Use of analgesic medications other than paracetamol during the study period
  • Physical therapy treatment for low back or radicular pain within the past 3 months
  • Contraindications to physical therapy modalities or Tecar therapy
  • Any previous lumbar spine surgery, or interventional spinal procedures within the last 6 months
  • Pregnancy, malignancy, or systemic neurological or rheumatologic disease
  • Advanced spinal or lower extremity deformities (e.g., scoliosis >20°, grade 3-4 spondylolisthesis, vertebral fracture, advanced coxarthrosis)
  • Inability to complete the intervention protocol or follow-up assessments

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Conventional Physical Therapy

Participants in this group will receive conventional physical therapy consisting of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS) applied to the lumbar region. Treatments will be administered five times per week for two weeks (10 sessions). Participants will also receive standardized postural education and a home exercise program.

Conventional physical therapy will include a combination of hot pack, continuous ultrasound therapy, and transcutaneous electrical nerve stimulation (TENS) applied to the lumbar region. Treatment sessions will be conducted five times per week for two weeks. Participants will also receive standardized postural education and a home exercise program.

Experimental: Tecar Therapy

Participants in this group will receive Tecar therapy in addition to standardized base physical therapy consisting of hot pack and TENS. Tecar therapy will be applied to the lumbar paraspinal region and gluteal muscles using capacitive and resistive modes with adjustable energy output. Sessions will be performed three times per week for two weeks. Participants will also receive standardized postural education and a home exercise program.

Tecar therapy (Transfer of Energy Capacitive and Resistive) will be applied using capacitive and resistive modes to the lumbar paraspinal region and gluteal muscles. Energy output will be adjusted to approximately 50-70% of the device capacity to achieve a comfortably warm sensation. Each session will last approximately 25 minutes and will be performed three times per week for two weeks. All applications will be delivered using a hypothermic electrode head.

Comparador falso: Arm Title

Participants in this group will receive sham Tecar therapy in addition to standardized base physical therapy consisting of hot pack and TENS. The sham procedure will follow the same protocol as the active Tecar therapy, including identical electrode contact and treatment duration, but the device will be set to zero energy output, preventing any thermal or electrical effect. Participants will also receive standardized postural education and a home exercise program.

Sham Tecar therapy will be delivered using the same device, electrode head, treatment duration, and therapist contact as the active Tecar therapy protocol. However, the device will be set to zero intensity output, preventing the delivery of electromagnetic energy or heat. This procedure is designed to mimic the active intervention while providing no therapeutic effect.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Radicular Leg Pain Intensity (Visual Analog Scale, VAS)
Periodo de tiempo: Baseline to Week 2

Change from baseline to Week 2 in average radicular leg pain over the previous 7 days, measured on a 10-cm VAS (0 = no pain, 10 = worst imaginable pain).

Baseline to Week 2

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Low Back Pain Intensity (VAS)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12

Average low back pain over the previous 7 days, measured on a 10-cm VAS.

Baseline, Week 2, Week 6, and Week 12
Radicular Leg Pain Intensity (VAS) at Follow-up
Periodo de tiempo: Baseline, Week 6, and Week 12

Average radicular leg pain over the previous 7 days, measured on a 10-cm VAS.

Baseline, Week 6, and Week 12
Neuropathic Pain Characteristics (PainDETECT Questionnaire)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12

Neuropathic pain features will be assessed using the PainDETECT Questionnaire, a validated self-report instrument ranging from -1 to 38 points. Higher scores indicate a greater likelihood of neuropathic pain components.

Baseline, Week 2, Week 6, and Week 12
Functional Disability (Oswestry Disability Index)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12

ODI version 2.0, percentage score from 0 to 100; higher scores indicate greater disability.

Baseline, Week 2, Week 6, and Week 12
Lumbar Mobility (Modified-Modified Schober Test)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12

Lumbar spine mobility will be assessed using the Modified-Modified Schober Test. The distance between two skin marks placed over the lumbar spine will be measured during maximal forward flexion.

Baseline, Week 2, Week 6, and Week 12
Nerve Root Irritability (Straight Leg Raise Test)
Periodo de tiempo: Baseline, Week 2, Week 6, and Week 12

The Straight Leg Raise (SLR) test will be used to assess nerve root irritability. The angle at which radicular pain is reproduced during passive leg elevation will be measured using a goniometer.

Baseline, Week 2, Week 6, and Week 12
Rescue Medication Consumption
Periodo de tiempo: Weeks 1, 2, 6, and 12

Total paracetamol intake (mg/week).

Weeks 1, 2, 6, and 12
Exercise Adherence
Periodo de tiempo: Weeks 1, 2, 6, and 12

Self-reported percentage of target home exercise sessions completed.

Weeks 1, 2, 6, and 12

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Treatment Credibility and Expectancy
Periodo de tiempo: Baseline

Credibility/Expectancy Questionnaire, administered before the first treatment session.

Baseline
Perceived Treatment Allocation
Periodo de tiempo: Week 2

Participant belief about the treatment received (active, control, or do not know), TECAR and sham groups only.

Week 2

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Ertan Yilmaz, MD, Izmir City Hospital

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

15 de abril de 2026

Finalización primaria (Estimado)

15 de abril de 2028

Finalización del estudio (Estimado)

15 de diciembre de 2028

Fechas de registro del estudio

Enviado por primera vez

14 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

14 de marzo de 2026

Publicado por primera vez (Actual)

18 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2024-KAEK-23

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be publicly shared due to institutional data protection policies and privacy regulations. Only aggregated data will be reported in scientific publications.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .